Croton schiedeanus schltd prevents experimental hypertension in rats induced by nitric oxide deficit

Brazilian Journal of Pharmaceutical Sciences

Volumn 49, Issue 4, 2013, Pages 865-871

  Páez, María Teresa ^a,b   Rodríguez, Diana Catalina ^a   López, Daniel Fernando ^a   Castañeda, Jorge Arturo ^a   Buitrago, Diana Marcela ^a,c   Cuca, Luis Enrique ^a   Guerrero, Mario Francisco ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

Almizelillo use hypertension prevention; Croton schiedeanus pharmacognosy; Hypertension prevention; Medicinal plants; Nitric oxide deficit; Plant extracts vasodilatation effects

Indexed keywords

ACETYLCHOLINE; CROTON SCHIEDEANUS EXTRACT; ENALAPRIL; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROTON SCHIEDEANUS; DRUG EFFICACY; EXPERIMENTAL HYPERTENSION; HEART RATE; IN VITRO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLANT LEAF; PLANT STEM; RAT; SYSTOLIC BLOOD PRESSURE; TRADITIONAL MEDICINE; VASCULAR RING; WISTAR RAT;

EID: 84897374432     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502013000400027     Document Type: Article

References (30)

1. ARNAL, J.F.; BATTLE, T.; RASETTI, C.; CHALLAH, M.; COSTEROUSSE, O.; VICAUT, E.; MICHEL, J.B.; Alhenc-Gelas, F. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am. J. Physiol., v.267, p.1777-1784, 1994.
2. CARRÓN, R.; SÁNZ, E.; PUEBLA, P.; MARTÍN, M.L.; SAN ROMÁN, L.; GUERRERO, M.F. Mechanisms of relaxation induced by flavonoid ayanin in isolated aorta rings from wistar rat. Colomb. Méd., v.41, p.10-16, 2010.
3. CHOCKALINGAM, A. World hypertension day and global awareness. Can. J. Cardiol., v.24, p.441-444, 2008.
4. Correa-Hernández, S.; Puebla-Ibáñez, P.; Carrón, R.; Martín-Calvo, L.; Román, L.; Guerrero-Pabón, M. Perfil vasodilatador de compuestos flavonoides y fenilbutanoides aislados de Croton schiedeanus schlecht. Rev. Fac. Med. Unal., v.56, p.291-301, 2008.
5. DAVISON, K.; BERRY, N.M.; MISAN, G.; COATES, A.M.; BUCKLEY, J.D.; HOWE, P.R. Dose-related effects of flavanol-rich cocoa on blood pressure. J. Hum. Hypertens., v.24, p.568-576, 2010.
6. DUARTE, J.; Pérez-Palencia, R.; Vargas, F.; Ocete, M.A.; Pérez-Vizcaino, F.; Zarzuelo, A.; Tamargo, J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol., v.133, p.117-124, 2001.
7. ESTRUCH, R.; ROS, E.; Salas-Salvadó, J.; Covas, M.I.; Pharm, D.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; Lamuela-Raventos, R.M.; Serra-Maje, M.L.; Pintó, X.; Basora, J.; Muñoz, M.A.; Sorlí, J.V.; Martínez, J.A.; Martínez-González, M.A. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J Med., v.368, p.1279-1290, 2013.
8. FORTE, P.; COPLAND, M. Basal nitric oxide synthesis in essential hypertension. Lancet, v.349, p.837-842, 1997.
9. García-Estaño, J.; Ortiz, M.C.; O'valle, F.; Alcaraz, A.; Navarro, E.G.; Vargas, F.; Evangelista, S.; Atucha, N.M. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats. Clin. Sci., v.110, p.227-233, 2006.
10. GUERRERO, M.F.; CARRÓN, R.; MARTÍN, M.L.; SAN ROMÁN, L.; REGUERO, M.T. Antihypertensive and vasorelaxant effects of aqueous extract from croton schiedeanus schlecht in rats. J. Ethnopharmacol., v.75, p.33-36, 2001.
11. GUERRERO, M.F.; PUEBLA, P.; CARRÓN, R.; MARTÍN, M.L.; ARTEAGA, L.; SAN ROMÁN, L. Assessment of the antihypertensive and vasodilator effects of ethanolic extracts of some Colombian medicinal plants. J. Ethnopharmacol., v.80, p.37-42, 2002b.
12. GUERRERO, M.F.; PUEBLA, P.; CARRÓN, R.; MARTÍN, M.L.; SAN ROMÁN, L. Quercetin 3,7-dimethyl ether, a vasorelaxant flavonoid isolated from croton schiedeanus schlecht. J. Pharm. Pharmacol., v.54, p.1373-1378, 2002c.
13. GUERRERO, M.F.; PUEBLA, P.; MARTÍN, M.L.; CARRÓN, R.; SAN ROMÁN, L.; REGUERO, M.T. Inhibitory effect of N(G)-nitro-L-arginine methyl ester on the anti-adrenergic response elicited by ayanin in the pithed rat. Planta Med., v.68, p.322--325., 2002b.
14. HABAUZIT, V.; MORAND, C. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health. Ther. Adv. Chronic Dis., v.3, p.87-106, 2012.
15. HALLIWELL, B. Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc. Res., v.73, p.341-347, 2007.
16. HU, M. Bioavailability of flavonoids and polyphenols: call to arms. Mol. Pharmacol., v.4, p.803-806, 2007.
17. JOVER, B.; MIMRAN, A. Nitric oxide inhibition and renal alterations. J. Cardiovasc. Pharmacol., v. 38, suppl.2, p.65-70, 2001.
18. KEARNEY, P.M.; WHELTON, M.; REYNOLDS, K.; MUNTNER, P.; WHELTON, P.K. Global burden of hypertension: analysis of world wide data. Lancet., v.9455, p.217-223, 2005.
19. LEE, Y.S.; KIM, C.H.; Yun-Choi, H.S.; Chang, K.C. Cardiovascular effect of a naphthylmethyl substituted tetrahydroisoquinoline, YS 49, in rat and rabbit. Life Sci., v.51, p.67-74, 1992.
20. MASON, R.P.; KUBANT, R., JACOB, R.F.; WALTER, M.F.; BOYCHUK, B.; MALINSKI, T. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant activity. J. Cardiovasc. Pharmacol., v.48, p.862-869, 2006.
21. MASON, R.P.; WALTER, M.F.; Jacob, R.F. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress. Circulation, v.109, suppl.1, p.1134-1141, 2004.
22. MASSION, P.B.; BALLIGAND, J.L. Relevance of nitric oxide for myocardial remodeling. Curr. Heart Fail Rep., v.4, p.18-25, 2007.
23. PANZA, J.A.; QUYYUMI, A.A.; CALLAHAN, T.S.; EPSTEIN, S.E. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol., v.21, p.1145-1151, 1993.
24. POLSTER, P.; CHRISTOPHE, B.; VAN DAMME, M.; HOULLICHE, A.; CHATELAIN, P. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies. J. Pharmacol. Exp. Ther., v.255, p.593-599, 1990.
25. TADDEI, S.; VIRDIS, A.; MATTEI, P.; ARZILLI, F.; SALVETTI, A. Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension. J. Cardiovasc. Pharmacol., v.20, suppl.12, p.193-195, 1992.
26. TSCHÖPE, C.; SCHULTHEISS, H.P.; WALTHER, T. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. J. Cardiovasc. Pharmacol., v.39, p.478-487, 2002.
27. TZEMOS, N.; LIM, P.O.; MACDONALD, T.M. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation, v.104, p.511-514, 2001.
28. VAN VLIET, N.B.; CHAFE, L.L.; VLADAN, A.; Schnyder-Candrian, S.; Montani, J.P. Direct and indirect methods used to study arterial blood pressure. J. Pharmacol. Toxicol. Methods, v.44, p.361-373, 2000.
29. VONLUEDER, T.G.; KRUM, H. RAAS inhibitors and cardiovascular protection in large scale trials. Cardiovasc. Drugs Ther., v.27, p.171-179, 2013.
30. ZHANG, Q.; PFAFFENDORF, M.; ZWIETEN, V. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br. J. Pharmacol., v.116, p.2963-2970, 1995.